← Back to work
Works cited by this work
21 works
Work: A comprehensive analysis of visfatin drug in type 2 diabetes, insulin resistance, and cardiovascular disease
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
Alexander R. Moschen, Arthur Kaser, Barbara Enrich +4
Article20072 citationsABIVisfatin: Structure, Function and Relation to Diabetes Mellitus and Other Dysfunctions
Review article20082 citationsABIThe release of the adipocytokine visfatin is regulated by glucose and insulin
Dominik G. Haider, G. Schaller, S. Kapiotis +3
Article20062 citationsABIStructure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme
Tao Wang, Xiangbin Zhang, Poonam Bheda +3
Article20062 citationsABISmall molecule regulation of Sir2 protein deacetylases
Olivera Grubisha, Brian C. Smith, John M. Denu
Review article20052 citationsABIExtension of Human Cell Lifespan by Nicotinamide Phosphoribosyltransferase
Eric van der Veer, Cynthia S.W. Ho, Caroline O’Neil +4
Article20072 citationsABIPre–B-Cell Colony-enhancing Factor as a Potential Novel Biomarker in Acute Lung Injury
Shui Q. Ye, Brett A. Simon, James P. Maloney +10
Article20042 citationsABIPlasma Visfatin Concentrations and Fat Depot–Specific mRNA Expression in Humans
Janin Berndt, Nora Klöting, Susan Kralisch +5
Article20052 citationsABI